Attached files
file | filename |
---|---|
EX-10.39 - EX-10.39 - Amphastar Pharmaceuticals, Inc. | amph-20191231ex1039dcc18.htm |
10-K - 10-K - Amphastar Pharmaceuticals, Inc. | amph-20191231x10k.htm |
EX-32.2 - EX-32.2 - Amphastar Pharmaceuticals, Inc. | amph-20191231ex322aed5b9.htm |
EX-32.1 - EX-32.1 - Amphastar Pharmaceuticals, Inc. | amph-20191231ex321a461e5.htm |
EX-31.2 - EX-31.2 - Amphastar Pharmaceuticals, Inc. | amph-20191231ex3129b82f0.htm |
EX-31.1 - EX-31.1 - Amphastar Pharmaceuticals, Inc. | amph-20191231ex3110cc8bc.htm |
EX-23.1 - EX-23.1 - Amphastar Pharmaceuticals, Inc. | amph-20191231ex231016219.htm |
EX-4.2 - EX-4.2 - Amphastar Pharmaceuticals, Inc. | amph-20191231ex42b840938.htm |
SUBSIDIARIES OF THE COMPANY
|
|
State of |
|
Country of |
|
|
Incorporation/ |
|
Incorporation/ |
Company Name |
|
Organization |
|
Organization |
International Medication Systems, Limited |
California |
United States of America |
||
Armstrong Pharmaceuticals, Inc. |
Massachusetts |
United States of America |
||
Amphastar Nanjing Pharmaceuticals, Inc. |
China |
|||
Nanjing Letop Fine Chemistry Co., Ltd. |
China |
|||
Nanjing Hanxin Medical Technology Co., Ltd. |
China |
|||
Nanjing Baixin Trading Co., Ltd. |
China |
|||
Amphastar France Pharmaceuticals, S.A.S. |
France |
|||
Amphastar UK Limited |
United Kingdom |
|||
International Medication Systems (UK) Limited |
United Kingdom |